Adult-Onset GliomaNCT00283569
Genetic Epidemiology of Adult Onset Glioma
An observational study of Adult-Onset Glioma, run by Kentuckiana Cancer Institute at 1 site in United States.
Trial summary
To establish a clinic based case control study for examination of potential risk factors for primary adult brain tumors. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Adult-Onset Glioma
- What is being tested?
- Mouth Swab, Toe Nail Clippings, Questionnaires
- How many people
- 100 participants
- Where
- 1 siteUnited States
- Study dates
- May 2004to Jan 2010
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Patients with Glioma and a Control
Who may be able to join
- primary glioma of any stage
- diagnosed within 4 months
Who cannot join
None listed.
Trial locations and contacts
1 site in 1 country.
United States1 site
Kentuckiana Cancer Institute
Louisville, Kentucky, 40202
About this study
Official title: Genetic Epidemiology of Adult-Onset Glioma
To establish a clinic based case control study for examination of potential risk factors for primary adult brain tumors.
Read the detailed description
Genetic epidemiology of adult glioma to establish potential risk factors for primary adult brain tumors.
- Conditions
- Adult-Onset Glioma
- Being tested
- Mouth Swab, Toe Nail Clippings, Questionnaires
- Keywords
- Glioma
- Medical subject headings
- Glioma
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Mouth Swab, Toe Nail Clippings, QuestionnairesOther
The objective of this study is to establish a clinic based case control study for examination of potential risk factors for primary adult brain tumors.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Jan 2006 (estimated)
- Study startMay 2004
- Primary completionJan 2010
- Study completionJan 2010
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Adult-Onset GliomaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Kentuckiana Cancer Institute
- Sponsor type
- University, hospital or other
- Collaborators
- DR. Kathleen Egan
- Investigators
- Renato V. LaRocca, MD, Principal investigator, Director
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00283569
- Sponsor's protocol ID
- mrbt1-03-132
- Other IDs
- MRBTC2003-01
- Status last verified
- Jan 2010
- First submitted
- 26 Jan 2006
- Last updated
- 20 Jan 2010
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 20 Jan 2010. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Genetic Epidemiology of Adult-Onset Glioma
- ClinicalTrials.gov ID
- NCT00283569
- Acronym / sponsor ID
- mrbt1-03-132
- Conditions
- Adult-Onset Glioma
- Keywords
- Glioma
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- Kentuckiana Cancer InstituteUniversity, hospital or other
- Collaborators
- DR. Kathleen Egan
- Study start
- May 2004
- Primary completion
- Jan 2010 (actual)
- Study completion
- Jan 2010 (actual)
- First posted
- 30 Jan 2006 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To establish a clinic based case control study for examination of potential risk factors for primary adult brain tumors.
Detailed description
Genetic epidemiology of adult glioma to establish potential risk factors for primary adult brain tumors.
Study design
- Observational model
- Case-control
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Patients with Glioma and a Control
Key inclusion criteria (2 listed)
- primary glioma of any stage
- diagnosed within 4 months
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Mouth Swab, Toe Nail Clippings, QuestionnairesThe objective of this study is to establish a clinic based case control study for examination of potential risk factors for primary adult brain tumors. | Other | – |
Primary outcome
Not reported in the source record.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Jan 2010.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Renato V. LaRocca, MD principal investigator
Director
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Adult-Onset Glioma, run by Kentuckiana Cancer Institute at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 20 Jan 2010. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jan 2010.